info:eu-repo/semantics/article
SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
Registro en:
Merello, Marcelo Jorge; Bhatia, Kailash P.; Obeso, Jose A.; SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy; Elsevier Science Inc.; Lancet Neurology; 20; 2; 2-2021; 94-95
1474-4422
CONICET Digital
CONICET
Autor
Merello, Marcelo Jorge
Bhatia, Kailash P.
Obeso, Jose A.
Resumen
During the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS and PNS, and the fact that this involvement is independent from the severity of the respiratory disease. Acute and subacute neurological complications of SARS-CoV-2 infections are reported in up to 85% of patients, including those with severe COVID-19, but also in otherwise minimally symptomatic or asymptomatic people. As many as 65% of people with COVID-19 present with hyposmia, which is also a common premotor symptom in Parkinson’s disease. This symptom, added to the fact that parkinsonism has been reported following COVID-19, has drawn the attention of the medical community to the hypothetical link between SARS-CoV-2 infection and Parkinson’s disease. Fil: Merello, Marcelo Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Bhatia, Kailash P.. No especifíca; Fil: Obeso, Jose A.. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina